Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.24.2.u1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Class A and Class B Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2023   263,741,000        
Beginning balance (in shares) at Jan. 31, 2023       14,131,000    
Beginning balance at Jan. 31, 2023 $ 549,332 $ 9 $ 1,074,149 $ (23,831) $ (4,384) $ (496,611)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation - equity classified awards 29,219   29,219      
Exercise of stock options and vesting of restricted stock units (in shares)   6,049,000        
Exercise of stock options and vesting of restricted stock units 21,350   21,350      
Issuance of common shares upon ESPP purchases (in shares)   528,000        
Issuance of common shares upon ESPP purchases 3,970   3,970      
Other adjustment 0 $ (1) 1      
Other comprehensive income (loss) 122       122  
Net income 13,293         13,293
Ending balance (in shares) at Jul. 31, 2023   270,318,000        
Ending balance (in shares) at Jul. 31, 2023       14,131,000    
Ending balance at Jul. 31, 2023 617,286 $ 8 1,128,689 $ (23,831) (4,262) (483,318)
Beginning balance (in shares) at Apr. 30, 2023   267,531,000        
Beginning balance (in shares) at Apr. 30, 2023       14,131,000    
Beginning balance at Apr. 30, 2023 578,852 $ 9 1,100,571 $ (23,831) (4,094) (493,803)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation - equity classified awards 15,489   15,489      
Exercise of stock options and vesting of restricted stock units (in shares)   2,259,000        
Exercise of stock options and vesting of restricted stock units 8,658   8,658      
Issuance of common shares upon ESPP purchases (in shares)   528,000        
Issuance of common shares upon ESPP purchases 3,970 $ 0 3,970      
Other adjustment 0 $ (1) 1      
Other comprehensive income (loss) (168)       (168)  
Net income 10,485         10,485
Ending balance (in shares) at Jul. 31, 2023   270,318,000        
Ending balance (in shares) at Jul. 31, 2023       14,131,000    
Ending balance at Jul. 31, 2023 $ 617,286 $ 8 1,128,689 $ (23,831) (4,262) (483,318)
Beginning balance (in shares) at Jan. 31, 2024   273,265,000        
Beginning balance (in shares) at Jan. 31, 2024 14,130,784     14,131,000    
Beginning balance at Jan. 31, 2024 $ 679,704 $ 8 1,182,150 $ (23,831) (3,836) (474,787)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation - equity classified awards 29,629   29,629      
Exercise of stock options and vesting of restricted stock units (in shares)   5,106,000        
Exercise of stock options and vesting of restricted stock units 17,235   17,235      
Issuance of common shares upon ESPP purchases (in shares)   455,000        
Issuance of common shares upon ESPP purchases 3,403   3,403      
Common stock repurchased, including accrued excise tax (in shares)   (25,460,000)        
Common stock repurchased, including accrued excise tax (273,064)         (273,064)
Other comprehensive income (loss) (415)       (415)  
Net income $ 12,475         12,475
Ending balance (in shares) at Jul. 31, 2024   253,366,000        
Ending balance (in shares) at Jul. 31, 2024 14,130,784     14,131,000    
Ending balance at Jul. 31, 2024 $ 468,967 $ 8 1,232,417 $ (23,831) (4,251) (735,376)
Beginning balance (in shares) at Apr. 30, 2024   268,114,000        
Beginning balance (in shares) at Apr. 30, 2024       14,131,000    
Beginning balance at Apr. 30, 2024 610,931 $ 8 1,205,948 $ (23,831) (5,224) (565,970)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation - equity classified awards 15,473   15,473      
Exercise of stock options and vesting of restricted stock units (in shares)   1,917,000        
Exercise of stock options and vesting of restricted stock units 7,593   7,593      
Issuance of common shares upon ESPP purchases (in shares)   454,000        
Issuance of common shares upon ESPP purchases 3,403   3,403      
Common stock repurchased, including accrued excise tax (in shares)   (17,119,000)        
Common stock repurchased, including accrued excise tax (171,247)         (171,247)
Other comprehensive income (loss) 973       973  
Net income $ 1,841         1,841
Ending balance (in shares) at Jul. 31, 2024   253,366,000        
Ending balance (in shares) at Jul. 31, 2024 14,130,784     14,131,000    
Ending balance at Jul. 31, 2024 $ 468,967 $ 8 $ 1,232,417 $ (23,831) $ (4,251) $ (735,376)